Recent Developments in Desensitization of Crossmatch-positive Kidney Transplant Recipients
Transplantation Proceedings, 08/03/2012
Morath C et al. – This review focuses on new advances in desensitization of crossmatch–positive kidney transplant recipients which include immunoadsorption and the administration of new substances such as the complement C5 inhibitor eculizumab. Finally, integrated algorithms that combine different measures are acknowledged.